Practical use of insulin degludec/insulin aspart in a multinational setting: beyond the guidelines

Insulin degludec/insulin aspart (IDegAsp) is a fixed‐ratio co‐formulation of insulin degludec, which provides long‐lasting basal insulin coverage, and insulin aspart, which targets postprandial glycaemia. This review provides expert opinion on the practical clinical use of IDegAsp, including: dose t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Diabetes Obes Metab
Autors principals: Mehta, Roopa, Chen, Roger, Hirose, Takahisa, John, Mathew, Kok, Adri, Lehmann, Roger, Unnikrishnan, Ambika Gopalakrishnan, Yavuz, Dilek Gogas, Fulcher, Gregory
Format: Artigo
Idioma:Inglês
Publicat: Blackwell Publishing Ltd 2020
Matèries:
Review Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7689716/
https://ncbi.nlm.nih.gov/pubmed/32618405
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.14128
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars